Envista (NVST) Stock Forecast & Price Target
$3.92B
Market Cap
40.10
P/E
15.95
Forward P/E
64
Score
NVST price $24.42 +0.48 +2.01%
Stocklytics score rationale: value 69, quality 58, growth 66.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 2785400000 | 2810900000 | 2844500000 | 2284800000 | 1929100000 | 2508900000 | 2569100000 | 2566500000 | 2510600000 | 2719500000 |
Envista Holdings Corporation is an enterprise dedicated to the development and distribution of a comprehensive range of dental solutions. These offerings are crucial for the identification, therapeutic intervention, and preventative care of diverse oral health issues, specifically addressing the teeth, gingiva (gums), and their supporting bone structures. The company's principal location is in Brea, California, and…
Consensus Buy from 16 analysts. Average price target $28.60, +17.1% versus the current price. Low $23.00. High $33.00.
Insights · Dividends · Forecast · Financials · Learn
Analysts have an average 12-month price target of $28.60 for Envista Holdings (NVST), 16.4% above the current price of $24.57. Of 16 analysts covering the stock, 8 rate it Buy or Strong Buy, 8 Hold, and 0 Sell or Strong Sell, giving a consensus of Buy.
Forecasts are third-party estimates and often wrong. They are not investment advice.
| Low | $23.00 |
|---|---|
| Average | $28.60 |
| High | $33.00 |
The average is 16.4% above the current price of $24.57.
Of 16 analysts, 8 rate Envista Holdings Buy or Strong Buy, 8 Hold, and 0 Sell or Strong Sell. The consensus label is Buy. That split is not a recommendation.
Analyst averages on file: 2026, EPS $1.53, revenue $2.88 billion. 2027, EPS $1.66, revenue $2.98 billion.
The Stocklytics Score for NVST is 64 out of 100. It averages value, quality, and growth against a large-cap US universe. It is not a price target and not a buy or sell rating. Fair value is a separate estimate on the fair value tab.
$28.60 average, with a published range of $23.00 to $33.00.
The consensus is Buy from 16 analysts. This is not a recommendation.
Analysts' average EPS estimate for 2026 on file is $1.53. The average revenue estimate is $2.88 billion.
No reliable forecast exists that far out.
The next earnings date is shown on the stock page when a future report is on the calendar. This forecast does not invent a date.
Related: Envista Holdings · Financials · Dividends · Compare · AI stocks
Capital is at risk. Stocklytics is operated by Stocklytics Inc., a Marshall Islands company. It is not regulated by the FCA and does not give investment advice.
$3.92B
Market Cap
40.10
P/E
15.95
Forward P/E
64
Score